Literature DB >> 11145683

High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway.

D D Eason1, G Blanck.   

Abstract

Gene activation in early development is highly dependent on precise concentrations of trans-acting factors for the activation of different genes at differing points in the embryo. Thus, not only is the presence or absence of a particular trans-activator or repressor relevant in determining gene activation, but also the concentration of the regulatory protein must be above or below a certain threshold for proper gene regulation. Signaling pathways in somatic cells are thought to represent cascades of on/off switches, mediated most commonly by phosphorylation. Here we demonstrate a quantitative mechanism for regulating the level of a component of the IFN-gamma signaling pathway that in effect represents the differential sensitivities of STAT1, IFN-regulatory factor-1, and class II trans-activator (CIITA) to IFN-gamma. Unlike developmental gene regulation, in which specificity of gene activation is a function of regulatory protein concentrations, specificity of gene activation in the IFN-gamma signaling pathway is regulated by the duration of the activation of the primary IFN-gamma-regulatory protein, STAT1. This result most likely explains previously reported data indicating that a minimum amount of IFN-gamma is required for MHC class II gene activation despite the fact that the level of the IFN-gamma-inducible factor directly required for MHC class II induction, CIITA, directly correlates with the level of MHC class II expression. The induction of a high level of CIITA is dependent on sustained IFN-gamma signaling. The possible implications of this result for tumorigenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145683     DOI: 10.4049/jimmunol.166.2.1041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Authors:  Laura Pisapia; Giovanna Del Pozzo; Pasquale Barba; Alessandra Citro; Paul E Harris; Antonella Maffei
Journal:  Results Immunol       Date:  2012-09-27

2.  Size matters: sequential mutations in tumorigenesis may reflect the stochastic effect of mutagen target sizes.

Authors:  Kimberly Long; Toaa Abuelenen; Libia Pava; Maya Bastille; George Blanck
Journal:  Genes Cancer       Date:  2011-10

3.  Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.

Authors:  A Osborne; H Zhang; W M Yang; E Seto; G Blanck
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Substantially reduced expression of PIAS1 is associated with colon cancer development.

Authors:  Domenico Coppola; Vevek Parikh; David Boulware; George Blanck
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-15       Impact factor: 4.553

5.  An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia.

Authors:  Andrea Diviney; Boris I Chobrutskiy; Saif Zaman; George Blanck
Journal:  Cancer Cell Int       Date:  2019-03-27       Impact factor: 5.722

6.  Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.

Authors:  Liang Zhang; Timothy E Peterson; Victor M Lu; Ian F Parney; David J Daniels
Journal:  PLoS One       Date:  2019-07-30       Impact factor: 3.240

Review 7.  Regulation of major histocompatibility complex class II gene expression in trophoblast cells.

Authors:  Shawn P Murphy; Jason C Choi; Renae Holtz
Journal:  Reprod Biol Endocrinol       Date:  2004-07-05       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.